Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site
Clinical trial NCT05110781 · TERMINATED
Trial details
- NCT number
- NCT05110781
- Sponsor
- University of California, Davis
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-07
- Primary completion
- 2022-05-02
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.